140
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Identification of substandard drug products using electronic tongue: cefdinir suspension as a pilot example

ORCID Icon, ORCID Icon, ORCID Icon, , ORCID Icon, & show all
Pages 3249-3258 | Published online: 16 Sep 2019

References

  • World Health Organization. Counterfeit Drugs: Guidelines for the Development of Measures to Combat Counterfeit Drugs. Geneva: World Health Organization; 1999.
  • Shakoor O, Taylor R, Behrens R. Assessment of the incidence of substandard drugs in developing countries. Trop Med Int Health. 1997;2(9):839–845.9315042
  • Mackey TK, Liang BA. The global counterfeit drug trade: patient safety and public health risks. J Pharm Sci. 2011;100(11):4571–4579. doi:10.1002/jps.2267921698604
  • Afu S. Incidence of substandard drugs in developing countries. Trop Med Int Health. 1999;4(1):73–79.10203177
  • Frankish H. WHO steps up campaign on counterfeit drugs. Lancet. 2003;362(9397):1730. doi:10.1016/S0140-6736(03)14891-X
  • Rodionova OY, Houmøller LP, Pomerantsev AL, et al. NIR spectrometry for counterfeit drug detection: a feasibility study. Anal Chim Acta. 2005;549(1–2):151–158. doi:10.1016/j.aca.2005.06.018
  • Caudron JM, Ford N, Henkens M, Mace C, Kiddle‐Monroe R, Pinel J. Substandard medicines in resource‐poor settings: a problem that can no longer be ignored. Trop Med Int Health. 2008;13(8):1062–1072. doi:10.1111/j.1365-3156.2008.02106.x18631318
  • Kenyon A, Layloff T. Rapid Screening of Pharmaceuticals by Thin-layer Chromatography. St Louis (MO): US Food and Drug Administration, Division of Drug Analysis; 1994.
  • Preparations WECoSfP, World Health Organization. WHO Expert Committee on Specifications for Pharmaceutical Preparations: Thirty-ninth Report. Vol. 39 World Health Organization; 2005.
  • World Health Organization. Basic Tests for Pharmaceutical Dosage Forms. World Health Organization; 1991.
  • Arzamastsev A, Dorofeev V, Konovalov A, Kochin VY, Lebedeva N, Titov I. Determining adulterated drugs by modern analytical techniques. Pharm Chem J. 2004;38(3):166–169. doi:10.1023/B:PHAC.0000034308.08754.33
  • Holmberg M, Eriksson M, Krantz-Rülcker C, et al. 2nd workshop of the second network on artificial olfactory sensing (NOSE II). Sens Actuators B Chem. 2004;101(1–2):213–223. doi:10.1016/j.snb.2004.02.054
  • Baldwin EA, Bai J, Plotto A, Dea S. Electronic noses and tongues: applications for the food and pharmaceutical industries. Sensors. 2011;11(5):4744–4766. doi:10.3390/s11050474422163873
  • Abu-Khalaf N, Zaid A, Jaradat N, et al. The taste of commercially available clarithromycin oral pharmaceutical suspensions in the palestinian market: electronic tongue and in vivo evaluation. Sensors. 2018;18(2):454. doi:10.3390/s18020454
  • Qneibi M, Jaradat N, Zaid AN, Abu-Khalaf N, Natsheh A-R, Hussen F. evaluation of taste, total phenols and antioxidant for fresh, roasted, shade dried and boiled leaves of edible Arum palaestinum Bioss. Marmara Pharm J. 2018;22:1. doi:10.12991/mpj.2018.40
  • Hashem H, Gouda AA, Hassan W. Development and validation of a rapid stability indicating chromatographic determination of cefdinir in bulk powder and dosage form using monolithic stationary phase. J Liq Chromatogr Relat Technol. 2012;35(12):1638–1648. doi:10.1080/10826076.2011.621154
  • Hamrapurkar P, Patil P, Phale M, Gandhi M, Pawar S. A developed and validated stability-indicating reverse-phase high performance liquid chromatographic method for determination of cefdinir in the presence of its degradation products as per International Conference on Harmonization guidelines. Pharm Methods. 2011;2(1):15–22. doi:10.4103/2229-4708.8108523781424
  • USP-NF. Cefdinir for oral suspension. 2013 [ Updated December 12, 2018]. Available from: https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisions/m2184_cefdinir_for_oral_solution.pdf. Accessed 1213, 2018.
  • World Health Organization. Stability testing of active pharmaceutical ingredients and finished pharmaceutical products. WHO Tech Rep Ser. 2009;953:87–123.
  • Haraguchi T, Yoshida M, Kojima H, Uchida T. Usefulness and limitations of taste sensors in the evaluation of palatability and taste-masking in oral dosage forms. Asian J Pharm Sci. 2016;11(4):479–485. doi:10.1016/j.ajps.2016.03.001
  • Alpha MOS. Astree II Manual Taste Sensor. France: Toulouse; 2009.
  • ICH E. Validation of Analytical Procedures: Text and Methodology. USA: ICH Steering Committee; 2005.
  • Harmonisation ICO Validation of analytical procedures: textand methodology Q2(r1). 1996 Available from: https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Quality/Q2_R1/Step4/Q2_R1__Guideline.pdf. Accessed 102, 2018.
  • Convention TUSP. Cefdinir for oral suspension. USP-NF. 2014.